Mupirocin
- Generic Name
- Mupirocin
- Brand Names
- Bactroban, Centany, Pirnuo
- Drug Type
- Small Molecule
- Chemical Formula
- C26H44O9
- CAS Number
- 12650-69-0
- Unique Ingredient Identifier
- D0GX863OA5
- Background
Mupirocin, formerly termed pseudomonic acid A, is a novel antibacterial agent with a unique chemical structure and mode of action apart from other antibiotic agents. Produced by fermentation using the organism Pseudomonas fluorescens, mupirocin is a naturally-occurring antibiotic that displays a broad-specturm activity against many gram-positive bacteria and...
- Indication
Indicated for the treatment of impetigo and secondary skin infections, leading to traumatic skin lesions, due to Staphylococcus aureus and Streptococcus pyogenes.
- Associated Conditions
- Impetigo, Impetigo caused by Staphylococcus aureus, Impetigo caused by streptococcus pyogenes, Secondary infection Skin infection, Staphylococcus aurea colonization of the nasal passage
- Associated Therapies
- -
Bacterial Decolonization Within Dyads
- Conditions
- Interventions
- First Posted Date
- 2024-08-07
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Duke University
- Target Recruit Count
- 20
- Registration Number
- NCT06541145
- Locations
- 🇺🇸
Duke University, Durham, North Carolina, United States
Effects of Topical Gentamicin on the Prevention of Peritoneal Dialysis Related Infection
- Conditions
- Interventions
- First Posted Date
- 2022-02-22
- Last Posted Date
- 2022-02-22
- Lead Sponsor
- Phramongkutklao College of Medicine and Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT05251584
- Locations
- 🇹🇭
Phramongkutklao Hospital, Ratchathewi, Bangkok, Thailand
Topical Antibiotics in Chronic Rhinosinusitis
- Conditions
- Interventions
- First Posted Date
- 2018-09-17
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 19
- Registration Number
- NCT03673956
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)
- First Posted Date
- 2018-04-05
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 42
- Registration Number
- NCT03489629
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
🇺🇸Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, United States
🇺🇸University of Washington Medical Center and Seattle Children's, Seattle, Washington, United States
S. Aureus Decolonization in HPN Patients.
- First Posted Date
- 2017-06-01
- Last Posted Date
- 2022-05-31
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 63
- Registration Number
- NCT03173053
- Locations
- 🇩🇰
Rigshospitalet, Copenhagen, Denmark
🇩🇰Aalborg Universitetshospital, Aalborg, Denmark
🇳🇱Radboud UMC, Nijmegen, Gelderland, Netherlands
Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT
- Conditions
- Interventions
- First Posted Date
- 2016-11-15
- Last Posted Date
- 2016-11-15
- Lead Sponsor
- Hospital Italiano de Buenos Aires
- Target Recruit Count
- 40
- Registration Number
- NCT02963129
- Locations
- 🇦🇷
Hospital Italiano de Buenos Aires, Gascon 450, Buenos Aires, Argentina
🇦🇷Hospital Italiano de Buenos Aires, Peron 4190, Ciudad Autonoma de Buenos Aires, Capital Federal, Argentina
Staph Household Intervention for Eradication (SHINE)
- Conditions
- Interventions
- First Posted Date
- 2015-10-09
- Last Posted Date
- 2024-05-23
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 835
- Registration Number
- NCT02572791
- Locations
- 🇺🇸
St. Louis Children's Hospital, Saint Louis, Missouri, United States
🇺🇸Washington University School of Medicine, Saint Louis, Missouri, United States
Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment)
- First Posted Date
- 2014-11-06
- Last Posted Date
- 2016-03-01
- Lead Sponsor
- Destiny Pharma Plc
- Target Recruit Count
- 12
- Registration Number
- NCT02284555
- Locations
- 🇬🇧
Simbec Reseach Ltd, Wales, United Kingdom
The Use of Antibiotic Sinonasal Rinse After Sinus Surgery
- First Posted Date
- 2014-08-18
- Last Posted Date
- 2017-06-26
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 68
- Registration Number
- NCT02218307
- Locations
- 🇺🇸
University of Miami Miller School of Medicine, ENT Dept, Miami, Florida, United States
Checklist to Prevent MRSA Surgical Site Infections
- Conditions
- Interventions
- First Posted Date
- 2014-08-13
- Last Posted Date
- 2021-03-11
- Lead Sponsor
- VA Office of Research and Development
- Target Recruit Count
- 1794
- Registration Number
- NCT02216227
- Locations
- 🇺🇸
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore, Maryland, United States
🇺🇸VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston, Massachusetts, United States
🇺🇸VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor, Michigan, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.